DEFINITIVE NOTICE & PROXY STATEMENT

Company

GT Biopharma, Inc.

Filed

April 4, 1997

Period of Report

May 9, 1997

Accession Number

0000929624-97-000395

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →